S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MLTX MoonLake Immunotherapeutics

41.54

0.81 (1.99%)

Last Updated: 02:36:13

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

MoonLake Immunotherapeut... (NASDAQ:MLTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more MoonLake Immunotherapeut... Charts.

MoonLake Immunotherapeut... (NASDAQ:MLTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more MoonLake Immunotherapeut... Charts.

MoonLake Immunotherapeutics News

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 26 February 2025 (4 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 26 February 2025 (4 hours ago) • Edgar (US Regulatory)

MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Wednesday 26 February 2025 (4 hours ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab
Wednesday 8 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis
Thursday 14 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (4 months ago) • Edgar (US Regulatory)

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update
Thursday 7 November 2024 (4 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 9 October 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 September 2024 (6 months ago) • Edgar (US Regulatory)

More MoonLake Immunotherapeutics News Articles

Intesa Sanpaolo

Playa Hotels & Resorts NV

INTESA SANPAOLO

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions